Spironolactone Orion

Medicinal product

(Invented) name

Spironolactone Orion

Active substance (s)

Spironolaktonas

Strength

50 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03DA01, Spironolactone

Marketing authorisation holder

Orion Corporation, Suomija

Date of authorisation

2012-03-07

Date of renewal

2016-01-04

Documents

2842 Pakuotės lapelis 2025 08 10.docx

2842 Spironolactone Orion PCS PL 2025 08 10.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

FI/H/0773/002/MR

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Spironolaktonas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
47141	60955	1060955	plačiakaklis indas	N30		Receptinis	LT/1/12/2842/003	Tiekiama	-	-	No	-	-	Download
51453	65348	1065348	plačiakaklis indas	N100		Receptinis	LT/1/12/2842/004	Netiekiama	-	-	No	-	-
54280	68271	1068271	plačiakaklis indas	N50		Receptinis	LT/1/12/2842/009	Netiekiama	-	-	No	-	-
115948	102049	1102049	lizdinė plokštelė	N30		Receptinis	LT/1/12/2842/012	Netiekiama	-	-	No	-	-
118636	104740	1104740	lizdinė plokštelė	N60		Receptinis	LT/1/12/2842/014	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2016-01-04	Perregistruotas
2012-03-07	Registruotas